vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and Vericel Corp (VCEL). Click either name above to swap in a different company.
COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $92.9M, roughly 1.5× Vericel Corp). On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
CCB vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $92.9M |
| Net Profit | — | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | 12.4% | 24.1% |
| Net Margin | — | 25.0% |
| Revenue YoY | -5.8% | 23.3% |
| Net Profit YoY | — | 17.3% |
| EPS (diluted) | $0.84 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $92.9M | ||
| Q3 25 | $144.7M | $67.5M | ||
| Q2 25 | $119.4M | $63.2M | ||
| Q1 25 | $139.5M | $52.6M | ||
| Q4 24 | $146.5M | $75.4M | ||
| Q3 24 | $151.1M | $57.9M | ||
| Q2 24 | $135.3M | $52.7M | ||
| Q1 24 | $148.4M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $13.6M | $5.1M | ||
| Q2 25 | $11.0M | $-553.0K | ||
| Q1 25 | $9.7M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $13.5M | $-901.0K | ||
| Q2 24 | $11.6M | $-4.7M | ||
| Q1 24 | $6.8M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | 12.4% | 24.1% | ||
| Q3 25 | 12.4% | 5.1% | ||
| Q2 25 | 12.0% | -3.2% | ||
| Q1 25 | 8.4% | -24.3% | ||
| Q4 24 | 11.7% | 24.5% | ||
| Q3 24 | 10.8% | -4.3% | ||
| Q2 24 | 11.1% | -11.5% | ||
| Q1 24 | 5.9% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | 9.4% | 7.5% | ||
| Q2 25 | 9.2% | -0.9% | ||
| Q1 25 | 7.0% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 8.9% | -1.6% | ||
| Q2 24 | 8.6% | -8.9% | ||
| Q1 24 | 4.6% | -7.5% |
| Q4 25 | $0.84 | $0.46 | ||
| Q3 25 | $0.88 | $0.10 | ||
| Q2 25 | $0.71 | $-0.01 | ||
| Q1 25 | $0.63 | $-0.23 | ||
| Q4 24 | $0.95 | $0.40 | ||
| Q3 24 | $0.97 | $-0.02 | ||
| Q2 24 | $0.84 | $-0.10 | ||
| Q1 24 | $0.50 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $491.0M | $354.6M |
| Total Assets | $4.7B | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $491.0M | $354.6M | ||
| Q3 25 | $475.3M | $321.9M | ||
| Q2 25 | $461.7M | $306.8M | ||
| Q1 25 | $449.9M | $295.5M | ||
| Q4 24 | $438.7M | $292.0M | ||
| Q3 24 | $331.9M | $257.5M | ||
| Q2 24 | $316.7M | $243.0M | ||
| Q1 24 | $303.7M | $233.9M |
| Q4 25 | $4.7B | $488.0M | ||
| Q3 25 | $4.6B | $453.3M | ||
| Q2 25 | $4.5B | $435.6M | ||
| Q1 25 | $4.3B | $424.6M | ||
| Q4 24 | $4.1B | $432.7M | ||
| Q3 24 | $4.1B | $390.4M | ||
| Q2 24 | $4.0B | $376.8M | ||
| Q1 24 | $3.9B | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $15.0M |
| Free Cash FlowOCF − Capex | $246.1M | $12.8M |
| FCF MarginFCF / Revenue | 178.3% | 13.8% |
| Capex IntensityCapex / Revenue | 6.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $15.0M | ||
| Q3 25 | $59.0M | $22.1M | ||
| Q2 25 | $66.0M | $8.2M | ||
| Q1 25 | $71.7M | $6.6M | ||
| Q4 24 | $259.8M | $22.2M | ||
| Q3 24 | $62.6M | $10.2M | ||
| Q2 24 | $72.1M | $18.5M | ||
| Q1 24 | $56.8M | $7.2M |
| Q4 25 | $246.1M | $12.8M | ||
| Q3 25 | $57.4M | $19.5M | ||
| Q2 25 | $64.0M | $81.0K | ||
| Q1 25 | $68.9M | $-7.6M | ||
| Q4 24 | $249.9M | $8.5M | ||
| Q3 24 | $60.2M | $-9.2M | ||
| Q2 24 | $69.5M | $1.8M | ||
| Q1 24 | $55.0M | $-6.8M |
| Q4 25 | 178.3% | 13.8% | ||
| Q3 25 | 39.7% | 28.8% | ||
| Q2 25 | 53.6% | 0.1% | ||
| Q1 25 | 49.4% | -14.5% | ||
| Q4 24 | 170.6% | 11.2% | ||
| Q3 24 | 39.8% | -15.9% | ||
| Q2 24 | 51.3% | 3.4% | ||
| Q1 24 | 37.1% | -13.3% |
| Q4 25 | 6.1% | 2.4% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 1.7% | 12.9% | ||
| Q1 25 | 2.0% | 27.0% | ||
| Q4 24 | 6.8% | 18.3% | ||
| Q3 24 | 1.6% | 33.5% | ||
| Q2 24 | 1.9% | 31.8% | ||
| Q1 24 | 1.2% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 4.34× | 4.35× | ||
| Q2 25 | 5.99× | — | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
